Urowebinar: Is immune therapy changing the way we think about early bladder cancer?

Urowebinar: Is immune therapy changing the way we think about early bladder cancer?

UROwebinar: Developments in perioperative immunotherapy for bladder and kidney cancersПодробнее

UROwebinar: Developments in perioperative immunotherapy for bladder and kidney cancers

UROWebinar: New insights in treatment of bladder cancer From localized to metastatic diseasesПодробнее

UROWebinar: New insights in treatment of bladder cancer From localized to metastatic diseases

Urowebinar: Treatment strategy in muscle invasive bladder cancerПодробнее

Urowebinar: Treatment strategy in muscle invasive bladder cancer

Urowebinar: New treatments development in NMIBCПодробнее

Urowebinar: New treatments development in NMIBC

Urowebinar: Practical management of bladder cancerПодробнее

Urowebinar: Practical management of bladder cancer

WEBINAR: How New Immune and Targeted Therapies are Changing Bladder Cancer TreatmentПодробнее

WEBINAR: How New Immune and Targeted Therapies are Changing Bladder Cancer Treatment

Bladder Cancer Immunotherapy: Building on a history of immune responseПодробнее

Bladder Cancer Immunotherapy: Building on a history of immune response

UROWebinar: Understanding the tumor micro environment in urological cancers to improve immunotherapyПодробнее

UROWebinar: Understanding the tumor micro environment in urological cancers to improve immunotherapy

UROwebinar: Difficult bladder cancer casesПодробнее

UROwebinar: Difficult bladder cancer cases

New and Emerging Therapeutic Strategies in Bladder CancerПодробнее

New and Emerging Therapeutic Strategies in Bladder Cancer

Urowebinar: Update on bladder cancer management what are we doing wrong BY MORGAN ROUPRETПодробнее

Urowebinar: Update on bladder cancer management what are we doing wrong BY MORGAN ROUPRET

UROwebinar: Patient stratification and risk related treatment of NMIBCПодробнее

UROwebinar: Patient stratification and risk related treatment of NMIBC

UROwebinar: Bladder neoplasms: Will a morphological classification become obsolete?Подробнее

UROwebinar: Bladder neoplasms: Will a morphological classification become obsolete?

Treatment landscape after progression on Enfortumab + Pembro in bladder cancerПодробнее

Treatment landscape after progression on Enfortumab + Pembro in bladder cancer

Examining the State of the Science on New Therapies in Bladder CancerПодробнее

Examining the State of the Science on New Therapies in Bladder Cancer

UROwebinar: IMAGINE Measuring Guidelines Adherence an important pan European collaborative projectПодробнее

UROwebinar: IMAGINE Measuring Guidelines Adherence an important pan European collaborative project

Evidence and Insights on Innovative Treatment for Bladder CancerПодробнее

Evidence and Insights on Innovative Treatment for Bladder Cancer

UROwebinar: Practical aspects of cancer pathology for urologists The 2023 WHO noveltiesПодробнее

UROwebinar: Practical aspects of cancer pathology for urologists The 2023 WHO novelties

Bladder Cancer: Understanding Immune-, Targeted-, and Antibody-Based Models for Patient CareПодробнее

Bladder Cancer: Understanding Immune-, Targeted-, and Antibody-Based Models for Patient Care

Актуальное